Class action law suits
HAVE YOU OR A LOVED ONE TAKEN DARVON?
home

recover money

class action lawsuits
explained


about us

attorney signup
site map


Receive automatic email notification of new class action investigations:



Darvon: Heart Attacks & Arrhythmia

 



If you or a loved one used Darvon and suffered a heart attack, heart arrhythmia, cardiac arrest, heart failure, accidental overdose or death, you may be entitled to recover money in a lawsuit. Contact a lawyer for a free review.

A team of class action attorneys and personal injury lawyers has launched an investigation into Darvon (also known as propoxyphene), a prescription drug pain medication or opioid used to treat mild to moderate pain that was sold by Xanodyne Pharmaceuticals, Inc.

The U.S. Food and Drug Administration (“FDA”) reportedly has announced that Xanodyne has agreed to withdraw Darvon from the U.S. market after the FDA received new clinical data showing that the drug Darvon puts patients at risk of potentially serious or even fatal heart rhythm abnormalities and concluded that the risks of the medication Darvon outweigh the benefits of Darvon.

Darvon lawsuit claims potentially being investigated include cases where Darvon patients suffered one or more of the following symptoms, side effects and injuries after taking Darvon:

  • Heart Attack
  • Heart Arrhythmia
  • Heart Arrhythmia Surgery
  • Myocardial Infarction
  • Cardiac Arrest
  • Sudden Death
  • Heart Related Death
  • Accidental Overdose
  • Heart Failure
  • Stroke

If you or a loved one have taken Darvon and suffered a heart attack, heart arrhythmia, cardiac arrest, heart failure, accidental overdose or death after taking Darvon, you may be entitled to compensation.**

**If you have used Darvon and suffer from any side effects, symptoms or injuries, we urge you to promptly consult your doctor or physician for an evaluation.

Fill out the form on the right for a free attorney review.


Fill out this form for a free review by a lawyer.
*
*
























*
*

*
*
*
*
*
*
*
*



*